{
    "Trade/Device Name(s)": [
        "T2Bacteria Panel",
        "T2Bacteria\u00ae Panel"
    ],
    "Submitter Information": "T2 Biosystems, Inc.",
    "510(k) Number": "K233184",
    "Predicate Device Reference 510(k) Number(s)": [
        "K172708"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QBX",
        "NSU"
    ],
    "Summary Letter Date": "February 8, 2024",
    "Summary Letter Received Date": "September 28, 2023",
    "Submission Date": "September 28, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.3960"
    ],
    "Regulation Name(s)": [
        "Nucleic Acid-Based Device For The Amplification, Detection, And Identification Of Microbial Pathogens Directly From Whole Blood Specimens"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Acinetobacter baumannii",
        "Enterococcus faecium",
        "Escherichia coli",
        "Klebsiella pneumoniae",
        "Pseudomonas aeruginosa",
        "Staphylococcus aureus"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "K2EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "T2Dx Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid amplification",
        "T2 Magnetic Resonance (T2MR) detection"
    ],
    "Methodologies": [
        "Qualitative nucleic acid amplification",
        "Magnetic resonance detection"
    ],
    "Submission Type(s)": [
        "Panel",
        "Cartridge",
        "Reagent",
        "Instrument",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for T2Bacteria Panel using nucleic acid amplification and T2MR to detect six bacterial species directly from whole blood on the T2Dx instrument",
    "Indications for Use Summary": "Qualitative test for direct detection of six bacterial species in K2EDTA human whole blood from patients with suspected bacteremia, as an aid in diagnosis; results used in conjunction with other clinical and laboratory data, not as sole basis for clinical decisions.",
    "fda_folder": "Microbiology"
}